Pharmaceutical

INV-347 by Inversago Pharma for Obesity: Likelihood of Approval

INV-347 is under clinical development by Inversago Pharma and currently in Phase I for Obesity.

Feb 20, 2024 - 18:00
INV-347 is under clinical development by Inversago Pharma and currently in Phase I for Obesity.
Read the original article

Tags:

Previous Article

Opinion: STAT+: I’ve reported on the health of every president since Reagan. Her...

Next Article

PF-07872412 by Pfizer for Streptococcal Pneumonia: Likelihood of Approval

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: U.S. medical schools aren’t teaching future doctors about 7.4 million of their patients

Opinion: U.S. medical schools aren’t teaching future do...

Dec 11, 2023

Listen: Vertex’s polarizing data, Aduhelm’s adieu, & an FDA icon

Listen: Vertex’s polarizing data, Aduhelm’s adieu, & an...

Feb 1, 2024

SGN-1 by Guangzhou Huajin Pharmaceutical Technology for...

Apr 19, 2024